Case Name: AVENTIS PHARMA S.A. and Sanofi-Aventis U.S., LLC, Plaintiffs-Appellants, v. SUN PHARMACEUTICAL INDUSTRIES, LTD. and Sun Pharma Global Fze, Defendants-Appellees
Court: United States Court of Appeals for the Federal Circuit
Jurisdiction: United States
Decision Date: 2011-02-04
Citations: 408 F. App'x 362
Docket Number: No. 2011-1095
Parties: AVENTIS PHARMA S.A. and Sanofi-Aventis U.S., LLC, Plaintiffs-Appellants, v. SUN PHARMACEUTICAL INDUSTRIES, LTD. and Sun Pharma Global Fze, Defendants-Appellees.
Judges: 
Reporter: West's Federal Appendix
Volume: 408
Pages: 362–363

Head Matter:
AVENTIS PHARMA S.A. and Sanofi-Aventis U.S., LLC, Plaintiffs-Appellants, v. SUN PHARMACEUTICAL INDUSTRIES, LTD. and Sun Pharma Global Fze, Defendants-Appellees.
No. 2011-1095.
United States Court of Appeals, Federal Circuit.
Feb. 4, 2011.

Opinion:
ON MOTION
ORDER
The appellants move without opposition to stay proceedings in this appeal pending the court's disposition in Aventis Pharma S.A. v. Hospira Inc., 2011-1018, -1047, and separately move for an extension of time to file their initial brief.
Upon consideration thereof,
It Is Ordered That:
(1) The motion to stay the briefing schedule is granted. The appellants are directed to inform this court, within 14 days of the issuance of this court's mandate in 2011-1018, -1047, concerning how they believe that this appeal should proceed. The appellees may also respond within that time.
(2) The motion for an extension of time is denied as moot.